Outcome by treatment dose
Outcome . | Time from HSCT, d . | 6 mg/m2, n = 14 . | 7.5 mg/m2, n = 2 . | 9 mg/m2, n = 13 . | Total, n = 29 . |
|---|---|---|---|---|---|
| Died | |||||
| Progressive disease | — | 10 (1 CR, 9 NR) | 1 (NR) | 11 (2 CR, 1 CRp, 8 NR) | 22 |
| HSCT | — | 4 | 1 | 4 | — |
| No HSCT | — | 6 | 0 | 7 | — |
| Other | — | — | — | — | 5 |
| Pneumonia | 52 | 1 (NR) | 0 | 0 | — |
| Multiorgan failure | 77 | 1 (NR) | 0 | 0 | — |
| Sepsis, acute renal failure | 53 | 1 (NR) | 0 | 0 | — |
| Respiratory failure | 42 | 0 | 0 | 1 (CRp) | — |
| Graft loss plus fungal sepsis | 60 | 0 | 0 | 1 (CRp) | — |
| Alive | |||||
| Remission | — | 1 (CR, 645 + d)* | 1 (CRp, 112 + d)† | 0 | 2 |
| HSCT | — | 0 | 1 | 0 | — |
| No HSCT | — | 1 | 0 | 0 | — |
| Total | — | 14 | 2 | 13 | 29 |
Outcome . | Time from HSCT, d . | 6 mg/m2, n = 14 . | 7.5 mg/m2, n = 2 . | 9 mg/m2, n = 13 . | Total, n = 29 . |
|---|---|---|---|---|---|
| Died | |||||
| Progressive disease | — | 10 (1 CR, 9 NR) | 1 (NR) | 11 (2 CR, 1 CRp, 8 NR) | 22 |
| HSCT | — | 4 | 1 | 4 | — |
| No HSCT | — | 6 | 0 | 7 | — |
| Other | — | — | — | — | 5 |
| Pneumonia | 52 | 1 (NR) | 0 | 0 | — |
| Multiorgan failure | 77 | 1 (NR) | 0 | 0 | — |
| Sepsis, acute renal failure | 53 | 1 (NR) | 0 | 0 | — |
| Respiratory failure | 42 | 0 | 0 | 1 (CRp) | — |
| Graft loss plus fungal sepsis | 60 | 0 | 0 | 1 (CRp) | — |
| Alive | |||||
| Remission | — | 1 (CR, 645 + d)* | 1 (CRp, 112 + d)† | 0 | 2 |
| HSCT | — | 0 | 1 | 0 | — |
| No HSCT | — | 1 | 0 | 0 | — |
| Total | — | 14 | 2 | 13 | 29 |